Coronavirus: Chinese firm says its vaccine candidate passes phase two clinical trials | South China Morning Post

Coronavirus: Chinese firm says its vaccine candidate passes phase two clinical trials | South China Morning Post: China National Biotec Group (CNBG) says tests show its vaccine is safe, and now looks to clinical trials overseas; China has five vaccines under clinical study, with Sinovac Biotech’s candidate also completing a phase two trial.